Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Matinas BioPharma Holdings, Inc. | 437,244 | reported | 01 Nov 2023 | tx 23+1,851,506−12 |
| Ohr Pharmaceutical Inc | 37,600 | reported | 09 Sept 2022 | tx 2+203,403 |
| GENZYME CORP | 2,375 | reported | 04 Apr 2011 | tx 6+11,875−11,875 |
| PROGENICS PHARMACEUTICALS INC | 0 | reported | 19 Jun 2020 | tx 4+56,393−56,393 |
| AVADEL PHARMACEUTICALS PLC | 0 | reported | 12 Feb 2026 | tx 33+496,857−468,962 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Feb 2026 | OTHER | AVADEL PHARMACEUTICALS PLC | 219,905 | 21.00 USD | |
| 12 Feb 2026 | OTHER | AVADEL PHARMACEUTICALS PLC | 8,057 | — | deriv |
| 12 Feb 2026 | OTHER | AVADEL PHARMACEUTICALS PLC | 60,000 | — | deriv |
| 12 Feb 2026 | OTHER | AVADEL PHARMACEUTICALS PLC | 42,000 | — | deriv |
| 12 Feb 2026 | OTHER | AVADEL PHARMACEUTICALS PLC | 42,000 | — | deriv |
| 12 Feb 2026 | OTHER | AVADEL PHARMACEUTICALS PLC | 42,000 | — | deriv |
| 12 Feb 2026 | OTHER | AVADEL PHARMACEUTICALS PLC | 33,000 | — | deriv |
| 12 Feb 2026 | OTHER | AVADEL PHARMACEUTICALS PLC | 11,000 | — | deriv |
| 12 Feb 2026 | OTHER | AVADEL PHARMACEUTICALS PLC | 11,000 | — | deriv |
| 29 Jul 2025 | GRANT_AWARD | AVADEL PHARMACEUTICALS PLC | 11,000 | 0.00 USD | |
| 29 Jul 2025 | GRANT_AWARD | AVADEL PHARMACEUTICALS PLC | 11,000 | 0.00 USD | deriv |
| 13 Jan 2025 | PURCHASE | AVADEL PHARMACEUTICALS PLC | 30,000 | 7.84 USD | first after silence |
| 30 Jul 2024 | GRANT_AWARD | AVADEL PHARMACEUTICALS PLC | 11,000 | 0.00 USD | |
| 30 Jul 2024 | GRANT_AWARD | AVADEL PHARMACEUTICALS PLC | 11,000 | 0.00 USD | deriv |
| 01 Nov 2023 | GRANT_AWARD | Matinas BioPharma Holdings, Inc. | 437,244 | 0.00 USD | deriv |
| 01 Aug 2023 | GRANT_AWARD | AVADEL PHARMACEUTICALS PLC | 33,000 | 0.00 USD | deriv |
| 18 May 2023 | PURCHASE | AVADEL PHARMACEUTICALS PLC | 13,000 | 13.93 USD | |
| 22 Nov 2022 | PURCHASE | AVADEL PHARMACEUTICALS PLC | 20,000 | 7.80 USD | |
| 14 Nov 2022 | GRANT_AWARD | Matinas BioPharma Holdings, Inc. | 142,657 | 0.00 USD | deriv |
| 09 Sept 2022 | GRANT_AWARD | Ohr Pharmaceutical Inc | 37,600 | 0.00 USD | deriv |
| 03 Aug 2022 | GRANT_AWARD | AVADEL PHARMACEUTICALS PLC | 42,000 | 0.00 USD | deriv |
| 31 May 2022 | PURCHASE | AVADEL PHARMACEUTICALS PLC | 15,000 | 2.16 USD | |
| 01 Jun 2022 | PURCHASE | AVADEL PHARMACEUTICALS PLC | 20,000 | 2.27 USD | |
| 27 May 2022 | PURCHASE | AVADEL PHARMACEUTICALS PLC | 15,000 | 2.45 USD | first after silence |
| 01 Jan 2022 | GRANT_AWARD | Ohr Pharmaceutical Inc | 165,803 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 13 Jan 2025.